Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo R Rueda

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
Cancer Letters|June 25, 2013
Ovarian tumor initiating cell populations persist following paclitaxel and carboplatin chemotherapy treatment in vivoKashmira Kulkarni-Datar, Sandra Orsulic, Rosemary Foster, et al.
EMBO Reports|June 19, 2010
Cables1 protects p63 from proteasomal degradation to ensure deletion of cells after genotoxic stressNing Wang, Lankai Guo, Bo R Rueda, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|March 6, 2014
Dendritic cells attenuate the early establishment of endometriosis-like lesions in a murine modelAleksandar K Stanic, Minji Kim, Aaron K Styer, et al.
Journal of Ovarian Research|September 17, 2016
Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancerLeslie A Garrett, Whitfield B Growdon, Bo R Rueda, et al.
Reproductive Biology and Endocrinology : RB&E|March 21, 2003
Signaling mechanisms in tumor necrosis factor alpha-induced death of microvascular endothelial cells of the corpus luteumJames K Pru, Maureen P Lynch, John S Davis, et al.
Endocrinology|October 26, 2002
Soluble Fas ligand activates the sphingomyelin pathway and induces apoptosis in luteal steroidogenic cells independently of stress-activated p38(MAPK)James K Pru, Isabel R Hendry, John S Davis, et al.
Human Reproduction Update|April 8, 2014
MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?Anatte E Karmon, Eden R Cardozo, Bo R Rueda, et al.
Reproductive Biology and Endocrinology : RB&E|August 18, 2016
MicroRNA-15b regulates reversion-inducing cysteine-rich protein with Kazal motifs (RECK) expression in human uterine leiomyomaYichun Guan, Lankai Guo, Lawrence Zukerberg, et al.
Cancer Biology & Therapy|May 24, 2005
Increased growth rate, delayed senescense and decreased serum dependence characterize cables-deficient cellsSandra D Kirley, Bo R Rueda, Daniel C Chung, et al.
International Journal of Molecular Sciences|January 28, 2026
Normalizing the Tumor Microenvironment: A New Frontier in Ovarian Cancer TherapyAdam P Jones, Yanxia Zhao, Bo R Rueda, et al.
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
Cancer Letters|June 25, 2013
Ovarian tumor initiating cell populations persist following paclitaxel and carboplatin chemotherapy treatment in vivoKashmira Kulkarni-Datar, Sandra Orsulic, Rosemary Foster, et al.
EMBO Reports|June 19, 2010
Cables1 protects p63 from proteasomal degradation to ensure deletion of cells after genotoxic stressNing Wang, Lankai Guo, Bo R Rueda, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|March 6, 2014
Dendritic cells attenuate the early establishment of endometriosis-like lesions in a murine modelAleksandar K Stanic, Minji Kim, Aaron K Styer, et al.
Journal of Ovarian Research|September 17, 2016
Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancerLeslie A Garrett, Whitfield B Growdon, Bo R Rueda, et al.
Reproductive Biology and Endocrinology : RB&E|March 21, 2003
Signaling mechanisms in tumor necrosis factor alpha-induced death of microvascular endothelial cells of the corpus luteumJames K Pru, Maureen P Lynch, John S Davis, et al.
Endocrinology|October 26, 2002
Soluble Fas ligand activates the sphingomyelin pathway and induces apoptosis in luteal steroidogenic cells independently of stress-activated p38(MAPK)James K Pru, Isabel R Hendry, John S Davis, et al.
Human Reproduction Update|April 8, 2014
MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?Anatte E Karmon, Eden R Cardozo, Bo R Rueda, et al.
Reproductive Biology and Endocrinology : RB&E|August 18, 2016
MicroRNA-15b regulates reversion-inducing cysteine-rich protein with Kazal motifs (RECK) expression in human uterine leiomyomaYichun Guan, Lankai Guo, Lawrence Zukerberg, et al.
Cancer Biology & Therapy|May 24, 2005
Increased growth rate, delayed senescense and decreased serum dependence characterize cables-deficient cellsSandra D Kirley, Bo R Rueda, Daniel C Chung, et al.
International Journal of Molecular Sciences|January 28, 2026
Normalizing the Tumor Microenvironment: A New Frontier in Ovarian Cancer TherapyAdam P Jones, Yanxia Zhao, Bo R Rueda, et al.
Pageof 13